The Road to 2020 and Beyond: Whats driving the In Vitro Diagnostics Industry? Alternative Scenarios of the Future IVD Market-Business-as-Usual, Economic Austerity, Technological Breakthroughs
This new report is designed to help executives develop effective contingency plans that best accommodate uncertainties ahead. The study objectives include:
To identify and evaluate emerging markets and technologies that may present unexpected threats or offer opportunities.
To identify key strategic decisions that will have to be made in the future.
To enhance corporate ability to develop realistic contingency plans.
To prepare executives to accommodate radically different operating climates and reduce surprises.
To challenge accepted perceptions of the future diagnostics market.
This report is an invaluable strategic planning resource for corporate, marketing and R&D executives. The strategic issues explored in the report include:
- How will the future reimbursement changes affect individual market segments?
- Will the industry consolidate, decentralize, or undergo a bimodal transformation?
- What will be the impact on purchasing influences, marketing strategies, joint ventures, mergers, licensing, import and export?
- How will the future technological advances affect the major market segment?
- Which companies will enter the market and which will not survive?
These and other key issues facing the decision-makers are explored in this thought-provoking and multi-faceted portrait of the three possible futures and their strategic implication. We would be glad to answer any questions you might have regarding this informative, comprehensive and insightful market research and technology assessment report, and look forward to your subscription.
Contains 255 pages and 32 tables
Please note: The delivery time for the electronic version of this report is between 1-3 business days to allow the preparation of an updated version prior to dispatch.
SIMILAR MARKET STUDIES
This new report from Venture Planning Group contains 537 pages, 42 tables, and presents a comprehensive analysis of the Japanese hospital cancer diagnostics market, including:
January 2014 | $3200 | View Details >>
2016 Canada Cancer Diagnostics Market: Emerging Cancer Diagnostics, Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains-Test Volume and Sales Forecasts, Competitive Strategies, Opportunities for Suppliers
This new report from VPGMarketResearch.com provides a strategic analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years. The report examines emerging trends in the cancer diagnostics market; reviews current and emerging tests; analyzes potential applications of innovative technologies; forecasts volume and sales ...
October 2016 | $0 | View Details >>
This new report from VPGMarketResearch provides analysis of Ammonia testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment. Geographic Coverage France, Germany, Italy, Japan, Spain, UK, USA Market Segmentation Centralized Testing; - Hospitals - Commercial/Private Laboratories POC/Decentralized Testing - Physician Offices/Group Practices - ...
July 2016 | $0 | View Details >>
This report provides: - Worldwide overview of the molecular diagnostics market, including France, Germany, Italy, Japan, Spain, UK and USA. - Estimates of facilities performing DNA sequencing and molecular diagnostic testing by country. - Five-year test volume and sales forecasts by country. Table of Contents 1. Worldwide Business Environment 2. Worldwide ...
March 2017 | $0 | View Details >>
UPCOMING MARKET RESEARCH REPORTS
2017 © Copyright Big Market Research